Nuwellis announces data demonstrating statistically superior clinical benefit of aquadex therapy in reducing heart failure events and mortality at the 2022 hfsa meeting

Statistically significant reduction in cv mortality and hf rehospitalizations as compared to iv diuretics at 30 and 90 days statistically significant reduction in cv mortality and hf rehospitalizations as compared to iv diuretics at 30 and 90 days
NUWE Ratings Summary
NUWE Quant Ranking